Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ifenprodil (NP-120) / Seyltx
Algernon Pharma_COVID-19: Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial	Not yet recruiting	3	100	US, Australia	ifenprodil (NP-120) - Algernon Pharma	Algernon Pharma	Moderate/severe COVID-19
Algernon Pharma_COVI: Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea	Not yet recruiting	2	40	South Korea	ifenprodil (NP-120) - Algernon Pharma	Algernon Pharma	COVID-19, severe pneumonia